Leupeptin is a small peptide microbially derived inhibitor of certain proteolytic enzymes. Using N-cx-benzoyl-DL-arginine 4-nitroanilide as substrate, we found a novel leupeptin-sensitive proteolytic enzyme in N-methyl-N-nitrosourea(MNU)-induced rat mammary adenocarcinoma. This enzyme was apparently different from urokinase-type plasminogen activator or cathepsin B and was present in mammary tumour at levels at least 20 times higher than those in normal mammary tissue. This enzyme was separated and purified from crude extracts of MNU-induced mammary adenocarcinoma approx. 1900-fold with 34 % yield. It was a trypsin-like serine endopeptidase and had a pH optimum at 7.0. The native enzyme had an apparent Mr of 180000 and exhibited four isoelectric points ranging from 4.3 to 5.0. Electrophoresis of denatured enzyme, however, yielded, with reduction, a major band with an apparent Mr of 37 500 and a minor band with an apparent Mr of 35500. The N-terminal 23 residues of the major band were
INTRODUCTION
Leupeptin (N-acetyl-(or N-propyl)L-leucyl-L-leucyl-L-argininal), isolated from Actinomycetes (Aoyagi et al., 1969a,b) , is an inhibitor of certain proteolytic enzymes which preferentially hydrolyse endopeptidase substrates at the carboxy side of a basic amino acid residue, either arginine or lysine (Aoyagi & Umezawa, 1975; Umezawa, 1976) . The argininal residue at the C-terminus of leupeptin is essential for its inhibitory activity Kondo et al., 1969) . In general, the proteolytic enzymes that are inhibited by leupeptin are grouped into two classes: trypsin-like serine endopeptidases and cathepsin B-like cysteine endopeptidases (Aoyagi & Umezawa, 1975; Umezawa, 1976 ).
An increased production of leupeptin-sensitive proteolytic enzymes has been observed in neoplastic mammary tissues. Cultured explants of mouse mammary adenocarcinoma and malignant human breast tumours have been shown to release excessive amounts of cathepsin B when compared with normal counterparts (Poole et al., 1978; Mort et al., 1980; Recklies et al., 1980 Recklies et al., , 1982a Mort & Recklies, 1986) . Urokinase-type plasminogen activator, a trypsin-like serine endopeptidase, has been found to be secreted in increased quantities from human breast cancer (Peterson et al., 1973; Nagy et al., 1977; Sherman et al., 1980; Sutherland, 1980; Evers et al., 1982; Thorsen, 1982; Needhan et al., 1988; Duffy et al., 1988; Pacheco et al., 1988) , rat mammary adenocarcinoma (O'Grady et al., 1981; Mira-y-Lopez et al., 1983) and mouse mammary tumours (Mira-y-Lopez et al., 1983; Pereyra-Alfonso et al., 1988; Kier Joffe, 1989) .
There is both direct and indirect evidence to suggest that proteolytic enzymes are involved in the process of tumour invasion and metastasis. Both cathepsin B and urokinase-type plasminogen activator have been implicated in playing a central role in the destruction and invasion of connective tissues by tumour cells (Mullins & Rohrlich, 1983; Dano et al., 1985; Goldfarb & Liotta, 1986; Mignatti et al., 1986; Hart & Rehemtulla, 1988; Clavel & Birembaut, 1988; Pollanen et al., 1988; Laiho & Keski-Oja, 1989) . Also, leupeptin has been shown to inhibit blood-borne lung metastases in rats injected intravenously with Yoshida ascites hepatoma cells (Saito et al., 1980) . Other studies have shown that leupeptin blocks tumour promotion in mouse skin (Hozumi et al., 1972) and suppresses carcinogenesis in many experimentally induced animal cancer models, including the 7,12-dimethylbenz [a] anthracene(DMBA)-induced rat mammary cancer model (Matsushima et al., 1976) .
Using N-a-benzoyl-DL-arginine 4-nitroanilide (Bz-Arg-4NA) as substrate, we found a novel leupeptin-sensitive serine endopeptidase in N-methyl-N-nitrosourea(MNU)-induced rat mammary adenocarcinoma (Eto & Bandy, 1990) . This enzyme appeared to be different from other leupeptin-sensitive serine endopeptidases, including urokinase-type plasminogen activator, and was detected at levels at least 20 times higher than those in normal mammary tissue. Here Grubbs et al. (1983 Grubbs et al. ( , 1985 and Moon et al. (1976) . All tumours used in the present study were classified histologically as either mammary adenocarcinomas or fibroadenomas. The tumours larger than approx. 3 cm in average diameter were often necrotic at the centre. Therefore, only the tumours smaller than 3 cm were used in the present study. In addition, all tumours used in the present study were sliced into two or three pieces with a pair of scissors and those that were found to be necrotic at the centre were discarded. Normal mammary tissues were obtained from the same stock of female rats (at about 230 days of age), except that they did not receive MNU or DMBA.
Enzyme assays
Hydrolysis of 4-nitroanilide substrates, including Bz-Arg-4NA, was assayed by continuously monitoring the absorbance of the product, 4-nitroaniline, at 410 nm using Varian DMS 200 u.v.-visible spectrophotometer. The preincubation mixture contained 0.1 M-potassium phosphate buffer, pH 6.9, and the enzyme preparation in a final volume of 1.0 ml. After incubation for 5 min at 37°C, the reaction was initiated by the addition of 10 ,1 of 0.1 M-4-nitroanilide substrate in dimethyl sulphoxide to the mixture. Enzyme blank without 4-nitroanilide substrate served as reference mixture. A substrate blank, which consisted of 1.0 ml of 0.1 M-potassium phosphate buffer, pH 6.9, and 10 ,u1 of 0.1 M-4-nitroanilide substrate in dimethyl sulphoxide, was used to correct the absorbance reading of the sample mixture. The molar absorption coefficient (e) of the product, 4-nitroaniline, at 410 nm was 1.016 x 104 M-1 cm-1 in 0.1 M-potassium phosphate buffer, pH 6.9. Initial velocities were calculated from the progress curve by the method of Waley (1981) .
Protein estimation
The protein concentration was determined by the dye-binding procedure of Bradford (1976) Preparation of partially purified enzyme A crude extract (approx. 60 ml) of MNU-induced mammary adenocarcinoma tissue was mixed with 2 vol. of 0.1 M-potassium phosphate buffer, pH 6.5, containing 0.6 M-NaCl and the mixture was divided into two equal parts and applied to two p-aminobenzamidine-agarose columns (1.5 cm x 12.5 cm). The columns were washed with 0.1 M-potassium phosphate buffer, pH 6.5, containing 0.4 M-NaCl (100 ml each) and the enzyme was eluted from the column with 0.1 M-sodium acetate buffer, pH 4.0, containing 0.4 M-NaCl (200 ml each). The pH of this enzyme solution was raised to 6.2 with I M-NaOH and the solution was concentrated to a small volume (2-4 ml) by stirred-cell ultrafiltration using a YM10 disc membrane (Amicon). The concentrated enzyme isolution was mixed with glycerol (to a final concentration of 50 o, w/v) and stored at -20 'C.
Five batches of the concentrated enzyme solution, which represented approx. 100 g of MNU-induced mammaryadenocarcinoma tissue, were pooled, concentrated to approx. 2 ml, and applied to a Sephacryl S-200 (Superfine grade) column (2.5 cm x 48 cm) that had been previously equilibrated with 0.1 M-potassium phosphate buffer, pH 6.5. The enzyme was eluted with the same buffer and fractions of 30 drops (approx. 1.5 ml) were collected. Active fractions were pooled, concentrated to approx. 2 ml, mixed with glycerol (to 50 %/o, w/v), and stored at -20 'C. The partially purified enzyme in 25 mM-Bistris/HCl buffer, pH 6.5, was applied to a Polybuffer Exchanger-94 column (1.0 cm x 50 cm), which had been equilibrated at 4 'C with the same buffer. The elution buffer was 560 ml of Polybuffer 74, which had been previously diluted 1:8 with degassed water and adjusted to pH 4.0 with HCI. Fractions consisting of 70 drops (approx. 3.4 ml) were collected.
PAGE
The apparent Mr of the denatured enzyme was estimated by gradient (5-15 %, w/v) PAGE in 0.1 % SDS using Protean II vertical-electrophoresis cells (Bio-Rad). Enzyme samples in glycerol sample buffer were boiled for 2 min in the presence or absence of 50% (v/v) 2-mercaptoethanol and 20% (w/v) SDS.
Gels were stained for protein with Coomassie Blue. The marker proteins used were rabbit muscle phosphorylase b (Mr 97400), BSA (66200), hen's-egg-white ovalbumin (42699), bovine carbonic anhydrase (31 000), soybean trypsin inhibitor (21 500) and hen's-egg-white lysozyme (14400). Bromophenol Blue was used as the tracking dye.
Mini-Protean II dual slab-electrophoresis cells (Bio-Rad) were used for discontinuous SDS/12 %-PAGE (Laemmli, 1970) . Enzyme samples in sucrose sample buffer containing 50 (v/v) 2-mercaptoethanol and 20% (w/v) SDS were boiled for 2 min, loaded on to 1.0 mm-thick slab mini-gels (5 % stacking gel; 12 % running gel) and run at 300 mA and 200 V for approx. 45 min.
Twice-recrystallized SDS was used for the sample buffer, stacking gel, and separating gel. Phenol Red was used as tracking dye.
N-Terminal amino-acid-sequence analysis
Approx. 30 ug of enzyme protein was applied to a discontinuous (Laemmli) SDS/polyacrylamide mini-gel (5 % stacking gel; 12% running gel) in a Mini-Protean II dual slabelectrophoresis cell (Bio-Rad). The proteins were transferred to 1992 Table 1 . Partial purification of Bz-Arg-4NA-hydrolysing activity from MNU-induced mammary adenocarcinoma of rat The enzyme was partially purified from 105 g of mammary adenocarcinoma. Crude extracts were obtained by homogenization of the tissues in 0.1 M-potassium phosphate buffer, pH 6.5, containing pepstatin A (1O #4g/ml) and bestatin hydrochloride (10 ,ug/ml) and centrifugation of the homogenate for 20 min at 23 400 g. Approx. 60 ml of the supernatant was divided into two portions and loaded on to two paminobenzamidine-agarose affinity columns (1.5 cm x 12.5 cm) at pH 6.5 and the enzyme was eluted at pH 4.0 as shown in Fig. 1 
RESULTS
Bz-Arg-4NA-hydrolysing activity in the crude extracts of mammary tumours and normal mammary tissue The Bz-Arg-4NA-hydrolysing activities in the crude extracts of mammary tumours and normal mammary tissue were assayed at pH 6.9. 2-Mercaptoethanol and EDTA were not included in the reaction mixture because these reagents did not increase or decrease specific Bz-Arg-4NA-hydrolysing activities. In addition, NaCl and Triton X-100 were omitted from the extraction buffer (0.1 M-potassium phosphate, pH 6.5) because inclusion of these reagents significantly decreased the specific enzyme activities by increasing the amount of proteins extracted without increasing the yield of enzyme activities. With these improvements incorporated in the extraction and enzyme-assay procedures, MNU-induced mammary adenocarcinoma contained the highest Bz-Arg-4NA-hydrolysing activity (4.94+0.33 nmol of 4-nitroaniline released/min per mg of protein at 37°C; n = 7). DMBAinduced mammary adenocarcinoma and fibroadenoma were also found to contain considerable Bz-Arg-4NA-hydrolysing activities: 2.95 + 0.31 (n = 5) and 1.13 + 0.32 (n = 2) nmol/min per mg of protein respectively. Normal mammary tissue exhibited the lowest activity (0.19 + 0.02 nmol/min per mg of protein; n = 5). All activities were completely inhibited by the addition of N-acetyl-leupeptin hemisulphate to the preincubation mixture at a final concentration of 50 ,ug/ml. Arg-4NA-hydrolysing activity present in the crude extracts of MNU-induced mammary adenocarcinoma A crude extract (approx. 30 ml), which was prepared in 0.1 Mpotassium phosphate buffer, pH 6.5, was mixed with 2 vol. of the same buffer containing 0.6 M-NaCl and applied to paminobenzamidine-agarose column (1.5 cm x 12.5 cm). Elution buffers were (a) 0.1 M-potassium phosphate buffer, pH 6.5 (100 ml) and (b) 0.1 M-sodium acetate buffer, pH 4.0 (200 ml). Both buffers contained 0.4 M-NaCl. The Bz-Arg-4NA-hydrolysing activity was assayed in 0.1 M-potassium phosphate buffer, pH 6.9, without 2-mercaptoethanol and EDTA. The pH of the eluted enzyme solution was raised to 6.2 and the solution was concentrated to a small volume by ultrafiltration. bestatin hydrochloride were added to the extraction buffer to suppress aspartate endopeptidase and leucine aminopeptidase activities present in the crude extract of MNU-induced mammary adenocarcinoma. As shown in Table 1 , p-aminobenzamidineagarose affinity chromatography was the most effective step in the separation and partial-purification procedure. Fig. 1 shows that most of the Bz-Arg-4NA-hydrolysing activity was absorbed top-aminobenzamidine-agarose beads at pH 6.5 and eluted from the beads at pH 4.0. The bulk of the proteins in the extract were not absorbed at pH 6.5. Since the activity of the enzyme was decreased substantially when it was exposed to elution buffer, the pH of the enzyme solution was quickly raised to 6.2 after elution to avoid inactivation. Addition of 0.1 M-benzamidine to the elution buffer did not increase the yield of enzyme from the column. The activity of the enzyme obtained after p-aminobenzamidine-agarose chromatography did not decrease for at Cbz-Gly-Gly-Leu-4NA The enzyme was separated and partially purified as described in the Experimental section. (a) pH optimum profile. Preincubation mixtures contained portions (5 ul) of the enzyme solution in 0.1 M buffers (1.0 ml; 0, phosphate; 0, acetate). A known amount of 4-nitroaniline dissolved in dimethyl sulphoxide was added to each buffer and the absorption at 410 nm was measured in order to calculate accurately the amount of 4-nitroaniline released from BzArg-4NA in different buffers. (b) pH stability profile. Portions (5 ,ul) of the enzyme solution were diluted with 0.1 M buffers to a final volume of 0.2 ml. After incubation for 30 min at 37°C without BzArg-4NA, 0.5 ml of 0.2 M-potassium phosphate buffer, pH 6.9, was added to the mixtures and the pH values were adjusted to 6.9 using either NaOH or HCI. The volumes were then adjusted to 1.0 ml before the addition of Bz-Arg-4NA.
least 6 months at -20°C in the presence of 50 % (w/v) glycerol.
Sephacryl S-200 chromatography of the active fraction (Fig. 2) showed that Bz-Arg-4NA-hydrolysing activity was eluted as a single peak between fl-amylase (Mr 200000) and alcohol dehydrogenase (Mr 150000). Starting with 105g of mammary adenocarcinoma tissue, 627 ,tg of partially-purified enzyme was obtained with 34 % yield and 1 900-fold purification.
Attempts to resolve this partially purified enzyme into two or more peaks were unsuccessful when the enzyme was chromatographed on heparin-agarose, CM-Sepharose Fast Flow, DEAESepharose Fast Flow and aprotinin-agarose columns under various conditions. pH optimum and stability
The partially purified enzyme was most active at pH values between 6.75 and 7.25 and most stable at pH 6.5 (Fig. 3) . The enzyme was unstable above pH 7.0 and below pH 5.5 (Fig. 3) . The apparent Mr of the enzyme as determined by gel-filtration chromatography on the Sepharose S-300 column did not change when the enzyme was exposed to pH 7.5 or 8.0 for 30 min at 37°C.
Substrate specificity and activation-inactivation studies As shown in Table 2 (Expt. 1), the partially purified enzyme did not hydrolyse seven substrates which had Pro, Ala, Leu, Val or Phe adjacent to the 4NA group. The two substrates which had Arg adjacent to the 4NA group (Cbz-Gly-Pro-Arg-4NA and Bz-Arg-4NA) were hydrolysed, but the aminopeptidase substrate (Arg-4NA) was not hydrolysed.
The specificity of hydrolysis of 11 Arg-or Lys-4NA endopeptidase substrates was then examined (Expt. 2 in Table 2 ). The (200000), alcohol dehydrogenase (150000), albumin (66000) and carbonic anhydrase (29000). The 0.1 M-potassium phosphate buffer, pH 6.5, was used for equilibration and elution. The enzyme was partially purified as described in the Experimental section and Table 1 . Glycerol was removed from the enzyme solution by ultrafiltration (YM10) and replaced with 0.1 Mpotassium phosphate buffer, pH 6.5. A 500 ,ul portion of this solution was applied to the column and fractions (15 drops; approx. 0.63 ml) were collected. The Bz-Arg-4NA-hydrolysing activity of each fraction was assayed in 0.1 M-potassium phosphate buffer, pH 6.9, as described in the Experimental section.
Arg-4NA-hydrolysing enzyme are presented in Table 3 . As shown in Expt. 1 (Table 3) , 2-mercaptoethanol and/or EDTA did not activate the enzyme and 4-(hydroxymercuri)benzoic acid and trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64) did not inhibit enzyme activity. The results of Expt. 2 (Table 3) shows that the enzyme was inhibited by leupeptin, antipain, benzamidine, tosyl-lysylchloromethane (Tos-LysCH2Cl) and phenylmethanesulphonyl fluoride, but not by elastase inhibitor (elastatinal), aspartate endopeptidase inhibitor (pepstatin), aminopeptidase inhibitors (amastatin, epiamastatin and bestatin), chymotrypsin inhibitors [chymostatin and tosylphenylalanylchloromethane (Tos-Phe-CH2Cl)] or metalloendopeptidase inhibitor (phosphoramidon). Of ten polypeptide inhibitors tested (Expt. 3 in Table 3 ), only two, namely bovine pancreatic trypsin inhibitor and bovine plasma aprotinin, were found to inhibit enzyme activity.
Analytical gel filtration and gel electrophoresis The apparent Mr of the partially purified Bz-Arg-4NA-hydrolysing enzyme was estimated by gel-filtration chromatography. A single peak of Bz-Arg-4NA-hydrolysing activity was eluted from a calibrated Sephacryl S-300 gel at a position slightly behind fl-amylase (Mr 200000) and ahead of alcohol dehydrogenase (Mr 150000) (Fig. 4) . On hen's-egg-white ovalbumin (42699), bovine carbonic anhydrase (31000), soybean trypsin inhibitor (21 500) and hen's-egg-white lysozyme (14400). TD indicates the position of tracking dye (Bromophenol Blue). Gels were stained for protein with Coomassie Blue.
31.0 21.5 -14.4 Fig. 7 . Gradient SDS/PAGE analysis of the partially purified enzyme resolved into four fractions (corresponding to peaks a, b, c, and d in Fig. 6 ) by Polybuffer Exchanger-94 chromatofocusing The fractions containing each of the four peaks, except for those that corresponded to the trough of two peaks, were pooled and concentrated to about 50-100 #1l by ultrafiltration using an Amicon YM1O membrane. The concentrated solution was boiled for 2 min in the presence of 2-mercaptoethanol and SDS and subjected to SDS/gradient-5-15Ol -PAGE as described in the legend to Fig. 5 . Approx. 1-3 jg of enzyme protein from each peak was applied to the gel. Lanes a, b, c, and d correspond to peaks a (pl 5.0), b (pI 4.7), c (pl 4.5) and d (pl 4.3) on the Polybuffer Exchanger-94 column respectively.
Mr of 37500 and a minor band (p35.5) with apparent Mr of 35500. There were six additional bands (p74, p71.5, p53, p49, p32, and p30.5) which stained faintly after prolonged Coomassie Blue staining. The position and composition of the bands did not change when the enzyme sample was boiled with SDS in the absence of 2-mercaptoethanol (results not shown). focusing The buffer (0.1 M-potassium phosphate buffer, pH 6.5) of the partially purified enzyme was replaced with 25 mM-Bistris/HCl buffer, pH 6.5, by ultrafiltration (Amicon's YM I0 membrane) and 2 ml of this solution (containing approx. 300 ,ug of protein) was applied to Polybuffer Exchanger-94 column (1.0 cm x 50.0 cm) which had been equilibrated with 25 mM-Bistris/HCl buffer, pH 6.5. Elution buffer was 560 ml of Polybuffer 74, which had previously been diluted 1 :8 with water and adjusted to pH 4.0 with HCI. Fraction (70 drops; approx. 3.4 ml) were collected. The Bz-Arg-4NA-hydrolysing activity was assayed in 0.1 M potassium phosphate buffer, pH 6.9, as described in the Experimental section.
Estimation of pl values by chromatofocusing
pl values for partially purified enzyme were estimated by chromatofocusing on Polybuffer Exchanger 94. As shown in Fig. 6 , the enzyme exhibited four isoelectric points, i.e. 5.0 (peak a), 4.7 (peak b), 4.5 (peak c), and 4.3 (peak d). SDS/5-15 %-gradient-PAGE analysis of these four peaks indicated that only two bands (p37.5 and p35.5) with apparent Mr values of 37500 and 35500 were present in all four peaks (Fig. 7) .
N-Terminal amino acid sequence analysis
Approx. 30 /ag of the partially purified enzyme was reduced, denatured and subjected to a discontinuous (Laemmli) SDS/12%-PAGE. Twice-recrystallized SDS was used for the sample buffer, stacking gel and separating gel. The protein bands were electroblotted on to a poly(vinylidene difluoride) membrane (Immobilon-P) as described in the Experimental section. The major protein band (p37.5) with an apparent Mr of 37500 was cut out, thoroughly destained and sequenced from the N-terminus by using an automated gas-phase sequencer with an online phenylthiohydantoin-derivative analyser.
The N-terminal amino acid sequence of the band p37.5 was
Leu22-Pro23. The N-terminal sequence of the minor band (p35.5) with apparent Mr of 35500 could not be determined. observation its apparent Mr was estimated to be approx. 180000. The apparent Mr remained unchanged for at least 6 months at 4°C in 0.1 M-potassium phosphate buffer, pH 6.5.
The SDS/5-15 .%-gradient-PAGE of denatured and reduced enzyme (Fig. 5) did not yield a band with an apparent Mr of 180000. Instead it yielded a major band (p37.5) with an apparent DISCUSSION Various properties of this enzyme suggest that it is a serine endopeptidase. This assignment is based on its (a) affinity adsorption on to p-aminobenzamidine-agarose (Fig. 1), (b) . >> (Table 3 ) and (c) the Ile'-Val2-GJy3-Gly4 sequence and Pro'3 residue, which are identical with those found in pancreatic trypsin and many other serine endopeptidases, where the Nterminal isoleucine residue has been shown to form an internal salt bridge on zymogen activation (Ruhlman et al., 1973; Young et al., 1978) . In addition, the results of the activation-inhibition studies (Table 3) (Table 2) . It is also inhibited by leupeptin, antipain and Tos-Lys-CH2Cl (Table 3) .
Furthermore, the results of the study of substrate specificity (Table 2 ) and sensitivity to various inhibitors (Table 3) indicate that it does not belong to the chymotrypsin subfamily (Phe-4-NA substrates, Tos-Phe-CH2Cl and chymostatin) or elastase subfamily (Leu-or Val-4NA substrates and elastatinal).
Although this is a trypsin-like enzyme, it is apparently different from other trypsin-like enzymes. No perfect match was found when the first 13 residues of the N-terminal sequence of this enzyme were compared with those in either the National Biomedical Research Foundation (NBRF) Protein Database or the University of Geneva Protein Sequence Data Bank (Swiss-Prot). This result suggested that either (a) this enzyme belongs to a known family of trypsin-like enzymes, but the N-terminal sequence of the rat enzyme has not yet been reported, or (b) it belongs to a new family distinct from any known trypsin-like enzymes.
To explore the first possibility, the 20 residues of this sequence were manually compared with those of other known trypsin-like enzymes and we found that they had the highest sequence similarity to those of mast-cell tryptases. The number of matched residues were 14 (70 %), 13 (65 %), and 12 (60 %) for human skin mast-cell tryptase, human lung mast-cell tryptase and dog mastocytoma tryptase respectively (Table 4) . Recently, the Nterminal amino acid sequence of rat skin tryptase has also become available in the literature (Braganza & Simmons, 1991) and comparison of the two sequences has revealed an even higher degree of similarity; the number of matched residues is 16 (80 %O identity) (Table 4) . Although this is not a perfect match, it suggests that this enzyme is similar to rat skin tryptase.
The structural and enzymic properties of this enzyme also suggest that it is similar to rat skin tryptase. (a) The apparent Mr of native enzyme is 180000 for this enzyme, 145 000 for rat skin tryptase (Braganza & Simmons, 1991) and 110000-144000 for rat peritoneal (Kido et al., 1985; Muramatu et al., 1988) , human (Smith et al., 1984; Schwartz, 1985 Schwartz, , 1989 Cromlish et al., 1987; Rochefort et al., 1987) and dog (Caughey et al., 1987) tryptases.
(b) The apparent Mr of the denatured enzyme is 37 500 (major) and 35 500 (minor) for this enzyme and 30000-37 500 for tryptases with two predominant bands approx. 1000-2000-Mr equivalents apart from one another. (c) pl values range from 4.3 to 5.0 for this enzyme and 4.5 to 4.9 for rat skin tryptase. (d) This enzyme is also relatively resistant to inactivation by many natural serine-proteinase inhibitors (Smith et al., 1984; Caughey et al., 1987; Cromlish et al., 1987) ; however, aptrotinin (or basic pancreatic trypsin inhibitor) inhibits this enzyme, rat skin tryptase, rat peritoneal mast-cell tryptase and dog mastocytoma tryptase, but it does not inhibit human tryptase. Also, soybean trypsin inhibitor and lima-bean trypsin inhibitor inhibit rat peritoneal-mast-cell tryptase (Kido et at., 1985) , but they do not inhibit this enzyme or any other tryptases, including rat skin tryptase. This enzyme appears to be more similar to rat tryptase than to other tryptases. Although this enzyme and all tryptases are rapidly inactivated at weakly alkaline pH values, heparin glycosaminoglycan does not protect this enzyme (results not shown), rat skin tryptase or rat peritoneal-mast-cell tryptase, whereas it protects other tryptases (Alter et al., 1987) . Also the inactivation of this mammary-tumour enzyme does not seem to be attributable to the dissociation of the active multimer, because the apparent Mr of the native enzyme, as determined by gel filtration, does not change under these conditions (results not shown).
In summary, all available evidence indicates that this enzyme most closely resembles rat skin tryptase, followed by rat peritoneal-mast-cell tryptase and then by tryptases from other species. The rat, like human and mouse, may carry multiple tryptase genes, and this mammary-tumour enzyme may be an additional form of rat tryptase within a new serine-proteinase family (Miller et al., 1990; Vanderslice et al., 1990; Braganza & Simmons, 1991) .
